RAFAEL HOLDINGS, INC. Adjustments to Additional Paid in Capital, Other
RAFAEL HOLDINGS, INC. (RFL) reported Adjustments to Additional Paid in Capital, Other of $7.26 million for the 12-month period ending 2024-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2024-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2024-04-30 was $7.26M.
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, other for fiscal 2024 was $7.26M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 3 month as first filed | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 9 month as first filed | Adjustments to Additional Paid in Capital, Other 12 month | Adjustments to Additional Paid in Capital, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $7.26M derived: sum of 2 quarters · filed 2025-10-29 | $7.26M 10-K · filed 2025-10-29 | $7.60M 10-K · filed 2024-11-07 | |||
| 2024-04-30 | $7.26M 10-Q · filed 2025-06-11 | $7.60M 10-Q · filed 2024-06-14 | $7.26M 10-Q · filed 2025-06-11 | $7.60M 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |